What MediciNova Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 1 |
| Total trades | 1 | 1 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 640,000 | 640,000 |
| Net activity | −640,000 | −640,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| 3D Investment Partners Pte. Ltd. | Insider | Sep 25 | Open-market sale · S | −640,000 | $2.70 | −$1.73M | 4,862,047 |
| Nagao Hideki | Director | Nov 28 | Open-market sale · S | −6,754 | $2.25 | −$15.2K | 0 |
| Nagao Hideki | Director | Nov 22 | Open-market sale · S | −218 | $2.13 | −$464 | 6,754 |
| Nagao Hideki | Director | Nov 21 | Open-market sale · S | −5,365 | $2.18 | −$11.7K | 6,972 |
| Nagao Hideki | Director | Nov 17 | Open-market sale · S | −309 | $2.18 | −$674 | 12,337 |
| Matsuda Kazuko | Chief Medical Officer | Aug 23 | Exercise / conversion · M | +60,000 | $2.30 | +$138K | 322,996 |
| Iwaki Yuichi | President and CEO | Jul 09 | Exercise / conversion · M | +39,583 | $2.54 | +$101K | 966,933 |
| Matsuda Kazuko | Chief Medical Officer | Jun 24 | Exercise / conversion · M | +56,250 | $2.46 | +$138K | 262,996 |
| Matsuda Kazuko | Chief Medical Officer | Jun 24 | Exercise / conversion · M | +46,554 | $2.54 | +$118K | 206,746 |
| OBrien Geoffrey | Vice President | May 19 | Exercise / conversion · M | +11,318 | $2.46 | +$27.8K | 48,318 |
| OBrien Geoffrey | Vice President | May 19 | Exercise / conversion · M | +32,000 | $2.54 | +$81.3K | 37,000 |
| Nagao Hideki | Director | Mar 11 | Open-market sale · S | −2,354 | $7.40 | −$17.4K | 12,646 |
| Iwaki Yuichi | President and CEO | Feb 25 | Exercise / conversion · M | +86,250 | $2.46 | +$212K | 927,350 |
| Nagao Hideki | Director | Sep 15 | Open-market sale · S | −1,000 | $5.78 | −$5.78K | 15,000 |
| Nagao Hideki | Director | Aug 06 | Exercise / conversion · M | +15,000 | $2.58 | +$38.7K | 16,000 |
| Matsuda Kazuko | Chief Medical Officer | Jun 12 | Exercise / conversion · M | +20,000 | $5.13 | +$103K | 160,192 |
| Matsuda Kazuko | Chief Medical Officer | Apr 08 | Exercise / conversion · M | +28,446 | $2.54 | +$72.3K | 140,192 |
| Iwaki Yuichi | President and CEO | Apr 08 | Exercise / conversion · M | +60,417 | $2.54 | +$153K | 841,100 |
| Matsuda Kazuko | Chief Medical Officer | Mar 13 | Open-market buy · P | +2,000 | $3.62 | +$7.24K | 111,746 |
| Iwaki Yuichi | President and CEO | Mar 12 | Open-market buy · P | +20,000 | $3.10 | +$62K | 780,683 |
Loading...
